XCUR · Company research
Exicure, Inc. Common Stock (XCUR): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Exicure (XCUR) Stock Analysis: -7.44% Loss — Key Levels 2026-10-15 - Gap Down Bounce Plays - https://www.siam.in/ | Exicure (XCUR) Stock Analysis: -7.44% Loss — Key Levels 2026-10-15 - Gap Down Bounce Plays https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 15, 2026 | neutral | 0 | 0.6 |
| Exicure Stock Price Forecast. Should You Buy XCUR? - StockInvest.us | Exicure Stock Price Forecast. Should You Buy XCUR? StockInvest.us | View source ↗ | StockInvest.us | Oct 9, 2026 | neutral | 0 | 0.6 |
| Exicure Inc. (XCUR) Slips to $1.22 as Shares Press Against Nearby Support - PSAR Stop - https://www.siam.in/ | Exicure Inc. (XCUR) Slips to $1.22 as Shares Press Against Nearby Support - PSAR Stop https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Sep 28, 2026 | neutral | 0 | 0.6 |
| Nasdaq gives Exicure until Dec. 2 to show it has $2.5 million left after debts - Stock Titan | Nasdaq gives Exicure until Dec. 2 to show it has $2.5 million left after debts Stock Titan | View source ↗ | Stock Titan | Sep 16, 2026 | neutral | 0 | 0.6 |
| Exicure (XCUR) Watch: Falls 11.54% to $1.15 in the Latest Session; Range View: Support at $1.09 and Resistance at $1.21 Frame the Range - Trend Following Picks - https://www.siam.in/ | Exicure (XCUR) Watch: Falls 11.54% to $1.15 in the Latest Session; Range View: Support at $1.09 and Resistance at $1.21 Frame the Range - Trend Following Picks https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Aug 22, 2026 | neutral | 0 | 0.6 |
| Exicure Announces Planned Issuance of Common Stock to Settle $1.0 Million Milestone Payment to GPCR Therapeutics - Quiver Quantitative | Exicure Announces Planned Issuance of Common Stock to Settle $1.0 Million Milestone Payment to GPCR Therapeutics Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 3, 2026 | neutral | 0 | 0.6 |
| XCUR Q2 2022 Earnings: EPS Misses Estimates, Stock Declines as Pre-Revenue Biotech Faces Challenges - dars.gov.et | XCUR Q2 2022 Earnings: EPS Misses Estimates, Stock Declines as Pre-Revenue Biotech Faces Challenges dars.gov.et | View source ↗ | dars.gov.et | Jul 22, 2026 | neutral | 0 | 0.6 |
| Unusual volume stocks are being observed in Wednesday's session. - ChartMill | Unusual volume stocks are being observed in Wednesday's session. ChartMill | View source ↗ | ChartMill | Jul 15, 2026 | neutral | 0 | 0.6 |
| How Exicure Inc. (XCUR) Affects Rotational Strategy Timing - Stock Traders Daily | How Exicure Inc. (XCUR) Affects Rotational Strategy Timing Stock Traders Daily | View source ↗ | Stock Traders Daily | Jul 13, 2026 | neutral | 0 | 0.6 |
| Exicure Inc. (XCUR) Slips 7.89%: Key Support Levels Under Scrutiny - McClellan Summation - dars.gov.et | Exicure Inc. (XCUR) Slips 7.89%: Key Support Levels Under Scrutiny - McClellan Summation dars.gov.et | View source ↗ | dars.gov.et | Jul 10, 2026 | neutral | 0 | 0.6 |
| Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch - Stocktwits | Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch Stocktwits | View source ↗ | Stocktwits | Dec 8, 2025 | neutral | 0 | 0.6 |
| Exicure (XCUR) Stock Price, News & Analysis - Stock Titan | Exicure (XCUR) Stock Price, News & Analysis Stock Titan | View source ↗ | Stock Titan | Apr 24, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Dec 10, 2023 | neutral | 0 | 0.6 |
| Bill Gates Slashes Investment in This Penny Biotech Stock - Barron's | Bill Gates Slashes Investment in This Penny Biotech Stock Barron's | View source ↗ | Barron's | Dec 22, 2021 | neutral | 0 | 0.6 |
| Exicure (XCUR) Stock Price, News & Analysis - MarketBeat | Exicure (XCUR) Stock Price, News & Analysis MarketBeat | View source ↗ | MarketBeat | Oct 22, 2020 | neutral | 0 | 0.6 |
| XCUR Stock Price and Chart — NASDAQ:XCUR - TradingView | XCUR Stock Price and Chart — NASDAQ:XCUR TradingView | View source ↗ | TradingView | Aug 2, 2019 | neutral | 0 | 0.6 |
| Exicure, Inc. (XCUR) Stock Price, News, Quote & History - Yahoo! Finance Canada | Exicure, Inc. (XCUR) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Aug 10, 2018 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.